89 related articles for article (PubMed ID: 3736043)
1. Synthesis of 19-noraldosterone, a potent mineralocorticoid.
Harnik M; Kashman Y; Cojocaru M; Rosenthal T; Morris DJ
J Steroid Biochem; 1986 Jun; 24(6):1163-9. PubMed ID: 3736043
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 19-hydroxyaldosterone and the 3 beta-hydroxy-5-ene analog of aldosterone, active mineralocorticoids.
Harnik M; Kashman Y; Aharonowitz Y; Morris DJ
J Steroid Biochem; 1985 Aug; 23(2):207-18. PubMed ID: 4033120
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 18-hydroxy-19-norcorticosterone and 18-deoxy-19-noraldosterone. Structure determination of related 19-nor steroids by means of 2-D 1H nmr.
Harnik M; Kashman Y; Carmely S; Cojocaru M; Dale SL; Holbrook MM; Melby JC
Steroids; 1986 Jan; 47(1):67-81. PubMed ID: 3810700
[TBL] [Abstract][Full Text] [Related]
4. Preparation of 3 beta, 5 alpha-, 3 alpha, 5 alpha- and 3 alpha, 5 beta-tetrahydro derivatives of 19-noraldosterone by chemical synthesis and microbial bioconversion.
Harnik M; Kashman Y; Carmely S; Cojocaru M
J Steroid Biochem; 1988 Jul; 31(1):97-105. PubMed ID: 3398535
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3 alpha, 5 alpha-tetrahydroaldosterone.
Harnik M; Kashman Y; Morris DJ
J Steroid Biochem; 1984 Jun; 20(6A):1313-20. PubMed ID: 6748646
[TBL] [Abstract][Full Text] [Related]
6. 18,21-Anhydroaldosterone and derivatives.
Harnik M; Kashman Y; Cojocaru M; Lewicka S; Vecsei P
Steroids; 1989 Jul; 54(1):11-9. PubMed ID: 2640565
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
Takeda Y; Miyamori I; Takeda R; Lewicka S; Vecsei P
J Clin Endocrinol Metab; 1992 May; 74(5):1195-7. PubMed ID: 1569167
[TBL] [Abstract][Full Text] [Related]
8. 18-Substituted steroids. Part 18. Chemical synthesis and mineralocorticoid activity of 2 alpha- and 2 beta-hydroxyaldosterone.
Kirk DN; Schröder MH; Latif SA; Souness GW; Morris DJ
Steroids; 1993 Feb; 58(2):59-63. PubMed ID: 8484185
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 18,19-dihydroxycorticosterone.
Harnik M; Carmely S; Cojocaru M; Kashman Y
Steroids; 1986; 47(2-3):205-13. PubMed ID: 3564087
[TBL] [Abstract][Full Text] [Related]
10. Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.
Takeda Y; Miyamori I; Yoneda T; Furukawa K; Inaba S; Takeda R; Mabuchi H
Hypertension; 1997 Oct; 30(4):953-6. PubMed ID: 9336399
[TBL] [Abstract][Full Text] [Related]
11. 18-Substituted steroids. Part 15. 6 beta-Hydroxylation of aldosterone by liver.
Kirk DN; Burke PJ; Toms HC; Latif SA; Morris DJ
Steroids; 1989 Aug; 54(2):169-84. PubMed ID: 2588296
[TBL] [Abstract][Full Text] [Related]
12. Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.
Takeda Y; Miyamori I; Yoneda T; Furukawa K; Hatakeyama H; Inaba S; Ito Y; Takeda R; Mabuchi H
J Clin Endocrinol Metab; 1996 May; 81(5):1852-5. PubMed ID: 8626846
[TBL] [Abstract][Full Text] [Related]
13. 19-Noraldosterone in pregnancy-induced hypertension.
Takeda Y; Yoneda T; Demura M; Furukawa K; Usukura M; Mabuchi H
Steroids; 2002 Jun; 67(7):605-10. PubMed ID: 11996933
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
15. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
Sekihara H; Island DP; Liddle GW
Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4,19-disubstituted derivatives of DOC. Radioreceptor assay of some corticosteroid derivatives in human mononuclear leukocytes.
Harnik M; Kashman Y; Cojocaru M; Bauer H; Laux M; Lewicka S; Vecsei P
J Steroid Biochem Mol Biol; 1990 Oct; 37(2):261-7. PubMed ID: 2268558
[TBL] [Abstract][Full Text] [Related]
17. Tetra- and hexahydro derivatives of aldosterone and 18-hydroxycorticosterone by chemical and microbial reductions.
Harnik M; Aharonowitz Y; Lamed R; Kashman Y
J Steroid Biochem; 1983 Oct; 19(4):1441-50. PubMed ID: 6645485
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid activity of reduced metabolites of aldosterone in rats [proceedings].
Morris DJ; DeConti GA; Latif SA
J Endocrinol; 1979 May; 81(2):111P-112P. PubMed ID: 458298
[No Abstract] [Full Text] [Related]
19. Mineralocorticoid activity of 21-deoxyaldosterone derivatives: structure-function studies.
Wynne KN; Rae ID; O'Keefe DF; Adam WR; Pearce P; Stockigt JR; Funder JW
J Steroid Biochem; 1981 Oct; 14(10):1041-4. PubMed ID: 6272022
[No Abstract] [Full Text] [Related]
20. 19-Noraldosterone.
Takeda Y
Crit Rev Biochem Mol Biol; 1999; 34(2):71-9. PubMed ID: 10333385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
